MARYAM HUSAIN: Open Payments
NPI 1023434065 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,368 in 78 payments from 16 companies in 2025. Trend: 2023 $274 · 2024 $1,231 · 2025 $1,368
Food & beverage: $1,350Education: $18
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $234 |
| ABBVIE INC. | 16 | $180 |
| E.R. Squibb & Sons, L.L.C. | 11 | $152 |
| Amgen Inc. | 9 | $149 |
| Lilly USA, LLC | 6 | $115 |
| UCB, Inc. | 1 | $111 |
| LEO Pharma Inc. | 5 | $88 |
| GENZYME CORPORATION | 4 | $81 |
| Arcutis Biotherapeutics, Inc. | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
Products named: NEMLUVIO, Sotyktu, Otezla, DUPIXENT, SKYRIZI, EBGLYSS, Bimzelx, Zoryve.
Industry payments across NJ — which companies pay providers there.
